Microcapsules and microcarriers for in situ cell delivery

Advanced Drug Delivery Reviews

Volumn 62, Issue 7-8, 2010, Pages 711-730

  Hernández, Rosa Ma ^a,b   Orive, Gorka ^a,b   Murua, Ainhoa ^a,b   Pedraz, José Luis ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Alginate PLL alginate; Cell encapsulation; Cell therapy; Drug delivery; Engineered cells; Stem cells

Indexed keywords

CELL ENCAPSULATION; CELL ENCAPSULATIONS; CELL MICROENCAPSULATION; CELL THERAPY; CELL TRANSPLANTS; CURRENT SITUATION; IMMUNE REJECTION; IMMUNE SYSTEMS; IN-SITU; KNOWLEDGE AND EXPERIENCE; LIVING CELL; MAIN EVENT; MICROCAPSULES; MICROCARRIERS; RAPID DEVELOPMENT; SEMIPERMEABLE POLYMERIC MEMBRANES; TECHNICAL ADVANCES; THERAPEUTIC PROTEIN; TRANSPLANTED CELLS; TUMORIGENESIS; XENOGENEIC CELLS;

ALGINATE; CELL IMMOBILIZATION; CYTOLOGY; DRUG DELIVERY; ENCAPSULATION; POLYMERIC MEMBRANES;

STEM CELLS;

AGAROSE; ALGINIC ACID; ANGIOSTATIN; BONE MORPHOGENETIC PROTEIN 2; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM ALGINATE; CHITOSAN; COLLAGEN; CYCLOSPORIN A; ENDOSTATIN; ERYTHROPOIETIN; GELATIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; INTERLEUKIN 12; MACROGOL DERIVATIVE; POLYGLACTIN; POLYLACTIC ACID; POLYORNITHINE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

BIOCOMPATIBILITY; BONE DISEASE; BREAST CANCER; CELL ENCAPSULATION; CELL MEMBRANE PERMEABILITY; CELL PROTECTION; CELL SURVIVAL; CELL TRANSPLANTATION; CHEMICAL MODIFICATION; CHONDROPATHY; CLINICAL TRIAL; COMPOSITE MATERIAL; DISTANT METASTASIS; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG PENETRATION; DRUG STABILITY; FIBROSARCOMA; GENETIC ENGINEERING; GLIOBLASTOMA; GLIOMA; HEART DISEASE; HEART FAILURE; HUMAN; HUNTINGTON CHOREA; IMMOBILIZED CELL; INSULIN DEPENDENT DIABETES MELLITUS; LIVER FAILURE; MALIGNANT NEOPLASTIC DISEASE; MATERIAL COATING; MELANOMA; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROCAPSULE; MICROENCAPSULATION; NEUROLOGIC DISEASE; NONHUMAN; PANCREAS CANCER; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROCESS TECHNOLOGY; REGENERATIVE MEDICINE; REVIEW; SURVIVAL TIME; TREATMENT INDICATION;

ANIMALS; CAPSULES; CELL TRANSPLANTATION; GENETIC ENGINEERING; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; POLYMERS; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

EID: 77953694901     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2010.02.004     Document Type: Review

References (250)

1. Kulig K.M., Vacanti J.P. Hepatic tissue engineering. Transpl. Immunol. 2004, 12:303-310.
2. Street C.N., Rajotte R.V., Korbutt G.S. Stem cells: a promising source of pancreatic islets for transplantation in type 1 diabetes. Curr. Top. Dev. Biol. 2003, 58:111-136.
3. Kim D., Schallert T., Liu Y., Browarak T., Nayeri N., Tessler A., Fischer I., Murray M. Transplantation of genetically modified fibroblasts expressing BDNF in adult rats with subtotal hemisection improves specific motor and sensory functions. Neurorehabil. Neural Repair 2001, 15:141-150.
4. Efrat S. Beta-cell replacement for insulin-dependent diabetes mellitus. Adv. Drug Deliv. Rev. 2008, 60:114-123.
5. Orive G., de Castro M., Ponce S., Hernández R.M., Gascón A.R., Bosch M., Alberch J., Pedraz J.L. Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules. Mol. Ther. 2005, 12:283-289.
6. Hortelano G., Chang P.L. Gene therapy for hemophilia. Artif. Cells Blood Substit. Immobil. Biotechnol. 2000, 28:1-24.
7. Cirone P., Bourgeois J.M., Austin R.C., Chang P.L. A novel approach to tumor suppression with microencapsulated recombinant cells. Hum. Gene Ther. 2002, 13:1157-1166.
8. Zilberman Y., Turgeman G., Pelled G., Xu N., Moutsatsos I.K., Hortelano G., Gazit D. Polymer-encapsulated engineered adult mesenchymal stem cells secrete exogenously regulated rhBMP-2, and induce osteogenic and angiogenic tissue formation. Polym. Adv. Technol. 2002, 13:863-870. utilizada en aplicaciones.
9. Orive G., Hernández R.M., Gascón A.R., Calafiore R., Chang T.M.S., de Vos P., Hortelano G., Hunkeler D., Lacík I., Pedraz J.L. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol. 2004, 22:87-92.
10. Uludag H., de Vos P., Tresco P.A. Technology of mammalian cell encapsulation. Adv. Drug Deliv. Rev. 2000, 42:29-64.
11. Herrero E.P., Martín del Valle E.M., Galán M.A. Immobilization of mesenchymal stem cells and monocytes in biocompatible microcapsules to cell therapy. Biotechnol. Prog. 2007, 23:940-945.
12. Allen T.M., Cullis P.R. Drug delivery systems: entering the mainstream. Science 2004, 303:1818-1822.
13. Agnihotri S.A., Mallikarjuna N.N., Aminabhavi T.M. Recent advances on chitosan-based micro and nanoparticles in drug delivery. J. Control. Release 2004, 100:5-28.
14. Soppimath K.S., Aminabhavi T.M., Kulkarni A.R., Rudzinski W.E. Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release 2001, 70:1-20.
15. Roney C., Kulkarni P., Arora V., Antich P., Bonte F., Wu A., Mallikarjuana N.N., Manohar S., Liang H.-F., Kulkarni A.R., Sung H.-W., Sairam M., Aminabhavi T.M. Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease. J. Control. Release 2005, 108:193-214.
16. Chang T.M.S. Attempts to find a method to prepare artificial hemoglobin corpuscles. Biomater. Artif. Cells Artif. Organs 1988, 16:1-9.
17. Torre M.L., Faustini M., Attilio K.M., Vigo D. Cell encapsulation in mammal reproduction, recent pat. Drug Deliv. Formul. 2007, 1:81-85.
18. Orive G., Hernández R.M., Gascón A.R., Calafiore R., Chang T.M.S., de Vos P., Hortelano G., Hunkeler D., Lacík I., Shapiro A.M., Pedraz J.L. Cell encapsulation: promise and progress. Nat. Med. 2003, 9:104-107.
19. Hunt N.C., Grover L.M. Cell encapsulation using biopolymer gels for regenerative medicine. Biotechnol. Lett. 2010, 32:733-742.
20. Joki T., Machluf M., Atala A., Zhu J., Seyfried N.T., Dunn I.F., Abe T., Carroll R.S., Black P.M. Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nat. Biotechnol. 2001, 19:35-39.
21. Chang T.M.S. Therapeutic applications of polymeric artificial cells. Nat. Rev. Drug Discov. 2005, 4:221-235.
22. Vermonden T., Fedorovich N.E., van Geemen D., Alblas J., van Nostrum C.F., Dhert W.J.A., Hennink W.E. Photopolymerized thermosensitive hydrogels: synthesis, degradation, and cytocompatibility. Biomacromolecules 2008, 9:919-926.
23. Rabanel J.M., Banquy X., Zouaoui H., Mokhtar M., Hildgen P. Progress technology in microencapsulation methods for cell therapy. Biotechnol. Prog. 2009, 25:946-963.
24. Chan G., Mooney D.J. New materials for tissue engineering: towards greater control over the biological response. Trends Biotechnol. 2008, 26:382-392.
25. Nikolovski J., Mooney D.J. Smooth muscle cell adhesion to tissue engineering scaffolds. Biomaterials 2000, 21:2025-2032.
26. M. Chayosumrit, B. Tuch, K. Sidhu, Alginate microcapsule for propagation and directed differentiation of hESCs to definitive endoderm, Biomaterials 31 (2010) 505-514.
27. Murua A., Orive G., Hernández R.M., Pedraz J.L. Xenogeneic transplantation of erythropoietin-secreting cells immobilized in microcapsules using transient immunosuppression. J. Control. Release 2009, 137:174-178.
28. Morris P.J. A critical review of immunosuppressive regimens. Transplant. Proc. 1996, 28:37-40.
29. Sgro C. Side-effects of a monoclonal antibody, Muromonab CD3/orthoclone OKT3: bibliographic review. Toxicology 1995, 105:23-29.
30. Weir M.R., Fink J.C. Risk for posttransplant diabetes mellitus with current immunosuppressive medications. Am. J. Kidney Dis. 1999, 34:1-13.
31. Paul A., Ge Y., Prakash S., Shum-Tim D. Microencapsulated stem cells for tissue repairing: implications in cell-based myocardial therapy. Regen. Med. 2009, 4:733-745.
32. Antosiak-Iwaska M., Sitarek E., Sabat M., Godlewska E., Kinasiewicz J., Weryski A. Isolation, banking, encapsulation and transplantation of different types of Langerhans islets. Pol. Arch. Med. Wewn. 2009, 119:311-316.
33. Wang T., Adcock J., Kühtreiber W., Qiang D., Salleng K.J., Trenary I., Williams P. Successful allotransplantation of encapsulated islets in pancreatectomized canines for diabetic management without the use of immunosuppression. Transplantation 2008, 85:331-337.
34. Peduto G., Rinsch C., Schneider B.L., Rolland E., Aebischer P. Long-term host unresponsiveness to encapsulated xenogeneic myoblasts after transient immunosuppression. Transplantation 2000, 70:78-85.
35. Dufrane D., Goebbels R.-M., Saliez A., Guiot Y., Gianello P. Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept. Transplantation 2006, 81:1345-1353.
36. Murua A., Portero A., Orive G., Hernández R.M., Pedraz J.L. Cell microencapsulation technology: towards clinical application. J. Control. Release 2008, 132:76-83.
37. Orive G., Anitua E., Pedraz J.L., Emerich D.F. Biomaterials for promoting brain protection, repair and regeneration. Nat. Rev. Neurosci. 2009, 10:682-692.
38. Zhang X., He H., Yen C., Ho W., Lee L.J. A biodegradable, immunoprotective, dual nanoporous capsule for cell-based therapies. Biomaterials 2008, 29:4253-4259.
39. Grandoso L., Ponce S., Manuel I., Arrúe A., Ruiz-Ortega J.A., Ulibarri I., Orive G., Hernández R.M., Rodríguez A., Rodríguez-Puertas R., Zumárraga M., Linazasoro G., Pedraz J.L., Ugedo L. Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats. Int. J. Pharm. 2007, 343:69-78.
40. Colton C.K. Implantable biohybrid artificial organs. Cell Transplant. 1995, 4:415-436.
41. Desai T.A., Hansford D.J., Ferrari M. Micromachined interfaces: new approaches in cell immunoisolation and biomolecular separation. Biomol. Eng. 2000, 17:23-36.
42. Robert P.L., William L.C., Willem M. Microcapsules and composite microreactors for immunoisolation of cells 1995, US Patent No: 402209.
43. de Vos P., Andersson A., Tam S.K., Faas M.M., Hallé J.P. Advances and barriers in mammalian cell encapsulation for treatment of diabetes. Immunol. Endocr. Metabol. Agents Med. Chem. 2006, 6:139-153.
44. Murua A., de Castro M., Orive G., Hernández R.M., Pedraz J.L. In vitro characterization and in vivo functionality of erythropoietin-secreting cells immobilized in alginate-poly-l-lysine-alginate microcapsules. Biomacromolecules 2007, 8:3302-3307.
45. Lim F., Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980, 210:908-910.
46. Consiglio A., Martino S., Dolcetta D., Cusella G., Conese M., Marchesini S., Benaglia G., Wrabetz L., Orlacchio A., Déglon N., Aebischer P., Severini G.M., Bordignon C. Metabolic correction in oligodendrocytes derived from metachromatic leukodystrophy mouse model by using encapsulated recombinant myoblasts. J. Neurol. Sci. 2007, 255:7-16.
47. Whitesides G.M. The origins and the future of microfluidics. Nature 2006, 442:368-373.
48. Qiu C., Chen M., Yan H., Wu H.K. Generation of uniformly sized alginate microparticles for cell encapsulation by using a soft-lithography approach. Adv. Mater. 2007, 19:1603-1607.
49. Orive G., Hernandez R.M., Gascon A.R., Pedraz J.L. Challenges in cell encapsulation. Applications of cell immobilisation biotechnology 2005, Vol. 8B:185-196. Springer, Netherlands.
50. Wilson J.T., Cui W., Chaikof E.L. Layer-by-layer assembly of a conformal nanothin PEG coating for intraportal islet transplantation. Nano Lett. 2008, 8:1940-1948.
51. Khademhosseini A., May M.H., Sefton M.V. Conformal coating of mammalian cells immobilized onto magnetically driven beads. Tissue Eng. 2005, 11:1797-1806.
52. Johnston A.P.R., Cortez C., Angelatos A.S., Caruso F. Layer-by-layer engineered capsules and their applications. Curr. Opin. Colloid Interface Sci. 2006, 11:203-209.
53. Caruso F. Hollow capsule processing through colloidal templating and self-assembly. Chemistry 2000, 6:413-419.
54. Li R.H. Materials for immunoisolated cell transplantation. Adv. Drug Deliv. Rev. 1998, 33:87-109.
55. Orive G., Hernández R.M., Gascón A.R., Igartua M., Pedraz J.L. Encapsulated cell technology: from research to market. Trends Biotechnol. 2002, 20:382-387.
56. Suksamran T., Opanasopit P., Rojanarata T., Ngawhirunpat T., Ruktanonchai U., Supapho P. Biodegradable alginate microparticles developed by electrohydrodynamic spraying techniques for oral delivery of protein. J. Microencapsul 2009, 26:563-570.
57. Haeberle, Naegele L., Burger R., Von Stetten F., Zengerle R., Ducrée J. Alginate bead fabrication and encapsulation of living cells under centrifugally induced artificial gravity conditions. J. Microencapsul 2008, 25:267-274.
58. Streule W., Lindemann T., Birkle G., Zengerle R., Koltay P. PipeJet: a simple disposable dispenser for the nano- and microliter range. J. Assoc. Lab. Automation 2004, 9:300-306.
59. Lanza R.P., Kuhtreiber W.M., Ecker D., Staruk J.E., Chick W.L. Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. Transplantation 1995, 59:1377-1384.
60. Tatard V.M., Venier-Julienne M.C., Saulnier P., Prechter E., Benoit J.P., Meneia P., Montero-Menei C.N. Pharmacologically active microcarriers: a tool for cell therapy. Biomaterials 2005, 26:3727-3737.
61. Stover N.P., Watts R.L. Spheramine for treatment of Parkinson's disease. Neurotherapeutics 2008, 5:252-259.
62. Falk T., Zhang S., Sherman S.J. Pigment epithelium derived factor (PEDF) is neuroprotective in two in vitro models of Parkinson's disease. Neurosci. Lett. 2009, 458:49-52.
63. Sommar P., Pettersson S., Ness C., Johnson H., Kratz G., Junker J.P.E. Engineering three-dimensional cartilage- and bonelike tissues using human dermal fibroblasts and macroporous gelatine microcarriers. J. Plast. Reconstr. Aesthet. Surg. 2010, 63:1036-1046.
64. Sun Z.J., Lu G.J., Li S.Y., Yu W.T., Wang W., Xie Y.B., Ma X. Differential role of microenvironment in microencapsulation for improved cell tolerance to stress. Appl. Microbiol. Biotechnol. 2007, 75:1419-1427.
65. Orive G., Tam S.K., Pedraz J.L., Hallé J.P. Biocompatibility of alginate-poly-l-lysine microcapsules for cell therapy. Biomaterials 2006, 20:3691-3700.
66. Benoit D.S., Schwartz M.P., Durney A.R., Anseth K.S. Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat. Mater. 2008, 7:816-823.
67. Orive G., de Castro M., Kong H.J., Hernández R.M., Ponce S., Mooney D.J., Pedraz J.L. Bioactive cell-hydrogel microcapsules for cell-based drug delivery. J. Control. Release 2009, 35:203-210.
68. Tibbitt M.W., Anseth K.S. Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol. Bioeng. 2009, 103:655-663.
69. Sakai S., Kawabata K., Ono T., Ijima H., Kawakami K. Development of mammalian cell-enclosing subsieve-size agarose capsules (<100?m) for cell therapy. Biomaterials 2005, 26:4786-4792.
70. Cellesi F., Weber W., Fussenegger M., Hubbel J.A., Tirelli N. Towards a fully synthetic substitute of alginate: optimization of a thermal gelation/chemical cross-linking scheme ("tandem" gelation) for the production of beads and liquid-core capsules. Biotechnol. Bioeng. 2004, 6:740-749.
71. Govan J.R.W., Fyfe J.A.M., Jarman T.R. Isolation of alginate-producing mutants of Pseudomonas fluorescens, Pseudomonas putida and Pseudomonas mendocina. J. Gen. Microbiol. 1981, 125:217-220.
72. Smidsrød O., Skjåk-Bræk G. Alginate as immobilization matrix for cells. Trends Biotechnol. 1990, 8:71-78.
73. Strand B.L., Mørch Y.A., Syvertsen K.R., Espevik T., Skjåk-Bræk G. Microcapsules made by enzymatically tailored alginate. J. Biomed. Mater. Res. A 2003, 64:540-550.
74. W.H.O. Environmental health criteria 161-phenols 1994, World Health Organization, Geneva.
75. Gernjak W., Krutzler T., Glaser A., Malato S., Caceres J., Brauer R., Fernandez-Alba A.R. Photo-fenton treatment of water containing natural phenolic pollutants. Chemosphere 2003, 50:71-78.
76. Zimmermann U., Klöck G., Federlin K., Haning K., Kowaslski M., Bretzel R.G., Horcher A., Entenmann H., Sieber U., Zekorn T. Production of mitogen contamination free alginates with variable rations of mannuronic to guluronic acid by free flow electrophoresis. Electrophoresis 1992, 13:269-274.
77. Klöck G., Frank H., Houben R., Zekorn T., Horcher A., Siebers U., Wohrle M., Federlin K., Zimmermann U. Production of purified alginate suitable for use in immunoisolated transplantation. Appl. Microbiol. Biotechnol. 1994, 40:638-643.
78. De Vos P., De Haan B.J., Wolters G.H.J., Strubbe J.H., Van Schilfgaarde R. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia 1997, 40:262-270.
79. Prokop A., Wang T.G. Purification of polymers used for fabrication of an immunoisolation barrier. Ann. N. Y. Acad. Sci. 1997, 831:223-231.
80. Jork A., Thurmer F., Cramer H., Zimmermann G., Gessner P., Hamel K., Hofmann G., Zimmermann U., Kuttler B., Hahn H.-J., Josimovic-Alasevic O., Fritsch K.-G. Biocompatible alginate from freshly collected Laminaria pallida for implantation. Appl. Microbiol. Biotechnol. 2000, 53:224-229.
81. Zimmermann U., Thurmer F., Jork A., Weber M., Mimietz S., Hillgartnet M., Brunnenmeier F., Zimmermann H., Westphal I., Fuhr G., Noth U., Haase A., Steinert A., Hendrich C. A novel class of amitogenic alginate microcapsules for long-term immunoisolated transplantation. Ann. N. Y. Acad. Sci. 2001, 944:199-215.
82. Dusseault J., Tam S.K., Ménard M., Polizu S., Jourdan G., Yahia L.H., Hallé J.P. Evaluation of alginate purification methods: effect on polyphenol, endotoxin, and protein contamination. J. Biomed. Mater. Res. A 2006, 76A:243-251.
83. Otterlei M., Østgaar K., Skjåk-Bræk G., Smidsrød O., Soon-Shiong P., Espevik T. Induction of cytokine production from human monocytes stimulated with alginate. J. Immunother. 1991, 10:286-291.
84. Espevik T., Ottrerlei M., Skjåk-Bræk G., Ryan L., Wright S.D., Sundan A. The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur. J. Immunol. 1993, 23:255-261.
85. Kulseng B., Skjåk-Bræk G., Ryan L., Anderson A., King A., Faxvaag A., Espevik T. Antibodies against alginates and encapsulated porcine islet-like cell clusters. Transplantation 1999, 67:978-984.
86. Soon-Shiong P., Otterlei M., Skjåk-Bræk G., Smidsrød O., Heintz R., Lanza P., Espevik T. An immunology basis for the fibrotic reaction to implanted microcapsules. Transplant. Proc. 1991, 23:758-759.
87. Clayton H.A., London N.J., Colloby P.S., Bell P.R., James R.F. The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules. J. Microencapsul 1991, 8:221-233.
88. de Vos P., De Haan B., van Schifgaarde R. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. Biomaterials 1997, 18:273-278.
89. de Vos P., van Schifgaarde R. Biocompatibility issues. Cell encapsulation technology and therapeutics 1999, 63-79. Birkhäuser, Boston. W.M. Kühtreiber, R.P. Lanza, W.L. Chick (Eds.).
90. Orive G., Ponce S., Hernández R.M., Gascón A.R., Igartua M., Pedraz J.L. Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates. Biomaterials 2002, 23:3825-3831.
91. Leinfelder U., Brunnenmeier F., Cramer H., Schiller J., Arnold K., Vásquez J.A., Zimmermann U. A highly sensitive cell assay for validation of purification regimes of alginates. Biomaterials 2003, 24:4161-4172.
92. Yamada K.M. Adhesive recognition sequences. J. Biol. Chem. 1991, 266:12809-12812.
93. Ruoslahti E. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol. 1996, 12:697-715.
94. Pinkse G.G., Bouwman W.P., Jiawan-Lalai R., Terpstra O.T., Bruijn J.A., de Heer E. Integrin signaling via RGD peptides and anti-beta1 antibodies confers resistance to apoptosis in islets of Langerhans. Diabetes 2006, 55:312-317.
95. Rowley J.A., Madlambayan G., Mooney D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 1999, 20:45-53.
96. Augst A.D., Kong H.J., Mooney D.J. Alginate hydrogels as biomaterials. Macromol. Biosci. 2006, 6:623-633.
97. Rowley J.A., Mooney D.J. Alginate type and RGD density control myoblast phenotype. J. Biomed. Mater. Res. 2002, 60:217-223.
98. Boontheekul T., Kong H.J., Hsiong S.X., Huang Y.C., Mahadevan L., Vandenburgh H., Mooney D.J. Quantifying the relation between bond number and myoblast proliferation. Faraday Discuss. 2008, 139:53-70.
99. Comisar W.A., Kazmers N.H., Mooney D.J., Linderman J.J. Engineering RGD nanopatterned hydrogels to control preosteoblast behavior: a combined computational and experimental approach. Biomaterials 2007, 28:4409-4417.
100. Kong H.J., Boontheekul T., Mooney D.J. Quantifying the relation between adhesion ligand-receptor bond formation and cell phenotype. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18534-18539.
101. Huebsch N.D., Mooney D.J. Fluorescent resonance energy transfer: a tool for probing molecular cell-biomaterial interactions in three dimensions. Biomaterials 2007, 28:2424-2437.
102. Silva E.A., Mooney D.J. Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J. Thromb. Haemost. 2007, 5:590-598.
103. Boontheekul T., Kong H.J., Mooney D.J. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials 2005, 26:2455-2465.
104. Rosenblatt J., Devereux B., Wallace D.G. Injectable collagen as a pH-sensitive hydrogel. Biomaterials 1994, 15:985-995.
105. Senuma Y., Franceschin S., Hilborn J.G., Tissieres P., Bisson I., Frey P. Bioresorbable microspheres by spinning disk atomization as injectable cell carrier: from preparation to in vitro evaluation. Biomaterials 2000, 21:1135-1144.
106. Chevallay B., Herbage D. Collagen-based biomaterials as 3D scaffold for cell cultures: applications for tissue engineering and gene therapy. Med. Biol. Eng. Comput. 2000, 38:211-218.
107. Roche S., Ronziere M.C., Herbage D., Freyria A.M. Native and DPPA cross-linked collagen sponges seeded with fetal bovine epiphyseal chondrocytes used for cartilage tissue engineering. Biomaterials 2001, 22:9-18.
108. Lee C.H., Singla A., Lee Y. Biomedical applications of collagen. Int. J. Pharm. 2001, 221:1-22.
109. Yannas I.V., Lee E., Orgill D.P., Skrabut E.M., Murphy G.F. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:933-937.
110. Yamada N., Uchinuma E., Kuroyanagi Y. Clinical evaluation of an allogeneic cultured dermal substitute composed of fibroblasts within a spongy collagen matrix. Scand. J. Plast. Reconstr. Surg. Hand Surg. 1999, 33:147-154.
111. Nimni M.E., Bernick S., Cheung D.T., Ertl D.C., Nishimoto S.K., Paule W.J., Salka C., Strates B.S. Biochemical differences between dystrophic calcification of cross-linked collagen implants and mineralization during bone induction. Calcif. Tissue Int. 1988, 42:313-320.
112. Murata M., Huang B.Z., Shibata T., Imai S., Nagai N., Arisue M. Bone augmentation by recombinant human BMP-2 and collagen on adult rat parietal bone. Int. J. Oral Maxillofac. Surg. 1999, 28:232-237.
113. Ratcliffe A. Tissue engineering of vascular grafts. Matrix Biol. 2000, 19:353-357.
114. Butler D.L., Awad H.A. Perspectives on cell and collagen composites for tendon repair. Clin. Orthop. 1999, 367:S324-S332.
115. Ma J., Wang H., He B., Chen J. A preliminary in vitro study on the fabrication and tissue engineering applications of a novel chitosan bilayer material as a scaffold of human neofetal dermal fibroblasts. Biomaterials 2001, 22:331-336.
116. Aiedeh K., Gianasi E., Orienti I., Zecchi V. Chitosan microcapsules as controlled release systems for insulin. J. Microencapsul 1997, 14:567-576.
117. Muzzarelli R., Baldassarre V., Conti F., Ferrara P., Biagini G., Gazzanelli G., Vasi V. Biological activity of chitosan: ultrastructural study. Biomaterials 1998, 9:247-252.
118. Tan W., Krishnaraj R., Desai T.A. Evaluation of nanostructured composite collagen-chitosan matrices for tissue engineering. Tissue Eng. 2001, 7:203-210.
119. Iwata H., Amemiya H., Matsuda T., Takano H., Hayashi R., Akutsu T. Evaluation of microencapsulated islets in agarose gel as bioartificial pancreas by studies of hormone secretion in culture and by xenotransplantation. Diabetes 1989, 38:224-225.
120. Rahfoth B., Weisser J., Sternkopf F., Aigner T., von der Mark K., Brauer R. Transplantation of allograft chondrocytes embedded in agarose gel into cartilage defects of rabbits. Osteoarthr. Cartil. 1998, 6:50-65.
121. Nuttelman C.R., Rice M.A., Rydholm A.E., Salinas C.N., Shah D.N., Anseth K.S. Macromolecular monomers for the synthesis of hydrogel niches and their application in cell encapsulation and tissue engineering. Prog. Polym. Sci. 2008, 33:167-179.
122. Santos E., Zarate J., Orive G., Hernández R.M., Pedraz J.L. Biomaterials in cell microencapsulation. Therapeutic applications of cell microencapsulation 2009, 5-21. Landes Bioscience, Austin. G. Orive, J.L. Pedraz (Eds.).
123. de Vos P., Bucko M., Gemeiner P., Navrátil M., Svitel J., Faas M., Strand B.L., Skjak-Braek G., Morch Y.A., Vikartovská A., Lacík I., Kolláriková G., Orive G., Poncelet D., Pedraz J.L., Ansorge-Schumacher M.B. Multiscale requirements for bioencapsulation in medicine and biotechnology. Biomaterials 2009, 30:2559-2570.
124. Wilson J.T., Chaikof E.L. Challenges and emerging technologies in the immunoisolation of cells and tissues. Adv. Drug Deliv. Rev. 2008, 60:124-145.
125. Yuet P.K., Harris T.J., Goosen M.F.A. Mathematical modeling of immobilized animal cell growth. Artif. Cells Blood Substit. Immobil. Biotechnol. 1995, 23:109-133.
126. Sakai S., Mu C., Kawabata K., Hashimoto I., Kawakami K. Biocompatibility of subsieve-size capsules versus conventional-size microcapsules. J. Biomed. Mater. Res. A 2006, 78:394-398.
127. Nelson C.M. Emergent patterns of growth controlled by multicellular form and mechanics. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11594-11599.
128. Ingber D.E. Mechanical control of tissue growth: function follows form. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11571-11572.
129. Downing B.R., Cornwell K., Toner M., Pins G.D. The influence of microtextured basal lamina analog topography on keratinocyte function and epidermal organization. J. Biomed. Mater. Res. A 2005, 72:47-56.
130. Renken A., Hunkeler D. Microencapsulation: a review of polymers and technologies with a focus on bioartificial organs. Polimery 1998, 43:530-539.
131. Sugiura S., Oda T., Izumida Y., Aoyagi Y., Satake M., Ochiai A., Ohkohchi N., Nakajima M. Size control of calcium alginate beads containing living cells using micro-nozzle array. Biomaterials 2005, 26:3327-3331.
132. Williams D.F. Summary and definitions. Progress in biomedical engineering: definition in biomaterials 1987, 66-71. Elsevier Science Ltd, Amsterdam. B.D. Ratner (Ed.).
133. Tam S.K., Dusseault J., Polizu S., Ménard M., Hallé J.P., Yahia L. Impact of residual contamination on the biofunctional properties of purified alginates used for cell encapsulation. Biomaterials 2006, 27:1296-1305.
134. Blasi P., Giovagnoli S., Schoubeen A., Ricci M., Rossi C., Luca G., Basta G., Calafiore R. Preparation and in vitro and in vivo characterization of composite microcapsules for cell encapsulation. Int. J. Pharm. 2006, 324:27-36.
135. Figliuzzi M., Plati T., Cornolti R., Adobati F., Fagiani A., Rossi L., Remuzzi G., Remuzzi A. Biocompatibility and function of microencapsulated pancreatic islets. Acta Biomater. 2006, 2:221-227.
136. de Vos P., Faas M.M., Strand B., Calafiore R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 2006, 27:5603-5617.
137. Chang T.M.S. Hybrid artificial cells: microencapsulation of living cells. ASAIO J. 1992, 38:128-130.
138. Loudovaris T., Charlton B., Hodgson R.J., Mandel T.E. Destruction of xenografts but not allografts within cell impermeable membranes. Transplant. Proc. 1992, 24:2291-2292.
139. Brauker J.H., Carr-Brendel V.E., Martinson L.A., Crudele J., Johnston W.D., Johnson R.C. Neovascularization of synthetic membranes directed by membrane microarchitecture. J. Biomed. Mater. Res. 1995, 29:1517-1524.
140. Padera R.F., Colton C.K. Time course of membrane microarchitecture-driven neovascularization. Biomaterials 1996, 17:277-284.
141. Geller R.L., Loudovaris T., Neuenfeldt S., Johnson R.C., Brauker J.H. Use of an immunoisolation device for cell transplantation and tumor immunotherapy. Ann. N. Y. Acad. Sci. 1997, 831:438-451.
142. de Vos P., de Haan B.J., Kamps J.A.A.M., Faas M.M., Kitano T. Zeta-potentials of alginate-PLL capsules: a predictive measure for biocompatibility?. J. Biomed. Mater. Res. A 2006, 80:813-819.
143. de Groot M., Schuurs T.A., van Schilfgaarde R. Causes of limited survival of microencapsulated pancreatic islet grafts. J. Surg. Res. 2004, 121:141-150.
144. A. Goren, N. Dahan, E. Goren, L. Baruch, M. Machluf, Encapsulated human mesenchymal stem cells: a unique hypoimmunogenic platform for long-term cellular therapy, FASEB J. 24 (2010) 22-31.
145. Bunger C.M., Tiefenbach B., Jahnke A., Gerlach C., Freier T., Schmitz K.P., Hopt U.T., Schareck W., Klar E., de Vos P. Deletion of the tissue response against alginate-pll capsules by temporary release of co-encapsulated steroids. Biomaterials 2005, 26:2353-2360.
146. Sakai S., Hashimoto I., Kawakami K. Development of alginate-agarose subsieve size capsules for subsequent modification with a polyelectrolyte complex membrane. Biochem. Eng. J. 2006, 30:76-81.
147. Khattak S.F., Chin K.S., Bhatia S.R., Roberts S.C. Enhancing oxygen tension and cellular function in alginate cell encapsulation devices through the use of perfluorocarbons. Biotechnol. Bioeng. 2007, 96:156-166.
148. Cheng D., Lo C., Sefton M.V. Effect of mouse VEGF164 on the viability of hydroxyethyl methacrylate-methyl methacrylate-microencapsulated cells in vivo: bioluminescence imaging. J. Biomed. Mater. Res. 2008, 87:321-331.
149. Massoud T.F., Singh A., Gambhir S.S. Noninvasive molecular neuroimaging using reporter genes: part I, principles revisited. Am. J. Neuroradiol. 2008, 29:229-234.
150. Barnett B.P., Kraitchman D.L., Lauzon C., Magee P., Walczak W.D., Wilson A., Arepally A., Bulte J.M.W. Radiopaque alginate microcapsules for X-ray visualization and immunoprotection of cellular therapeutics. Mol. Pharm. 2006, 3:531-538.
151. Fu Y., Kedziorek D., Ouwerkerk R., Crisostomo V., Gilson W., Azene N., Arepally A., Lorenz C., Shea S., Krieg R., Bulte J.W.M., Kraitchman D.L. Multifunctional perfluorooctylbromide alginate microcapsules for monitoring of mesenchymal stem cell delivery using CT and MRI. J. Cardiovasc. Magn. Reson. 2009, 11(Suppl 1):O7.
152. Barnett B.P., Arepally A., Karmarkar P.V., Qian D., Gilson W.D., Walczak P., Howland V., Lawler L., Lauzon C., Stuber M., Kraitchman D.L., Bulte J.W.M. Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells. Nat. Med. 2007, 13:986-991.
153. Malafaya P.B., Silva G.A., Reis R.L. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv. Drug Deliv. Rev. 2007, 59:207-233.
154. Shapiro A.M., Lakey J.R., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., Kneteman N.M., Rajotte R.V. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 2000, 343:230-238.
155. Calafiore R., Basta G. Artificial pancreas to treat type 1 diabetes mellitus. Methods Mol. Med. 2007, 140:197-236.
156. Jones P.M., Courtney M.L., Burns C.J., Persaud S.J. Cell-based treatments for diabetes. Drug Discov. Today 2008, 13:888-893.
157. Cruise G.M., Hegre O.D., Lamberti F.V., Hager S.R., Hill R., Scharp D.S., Hubbell J.A. In vitro and in vivo performance of porcine islets encapsulated in interfacially photopolymerized poly(ethylene glycol) diacrylate membranes. Cell Transplant. 1999, 8:293-306.
158. Cruise G.M., Hegre O.D., Scharp D.S., Hubbell J.A. A sensitivity study of the key parameters in the interfacial photopolymerization of poly (ethylene glycol) diacrylate upon porcine islets. Biotechnol. Bioeng. 1998, 57:655-665.
159. Sefton M.V., Kharlip L. Insulin release from rat pancreatic islets microencapsulated in a HEMA-MMA polyacrylate. Pancreatic islet transplantation, Vol. III: immunoisolation of pancreatic islets 1994, 107-117. Landes Bioscience, Austin. R. Lanza, W. Chick (Eds.).
160. Schaffellner S., Stadlbauer V., Stiegler P., Hauser O., Halwachs G., Lackner C., Iberer F., Tscheliessnigg K.H. Porcine islet cells microencapsulated in sodium cellulose sulfate. Transplant. Proc. 2005, 37:248-252.
161. Kobayashi T., Aomatsu Y., Kanehiro H., Hisanaga M., Nakajima Y. Protection of NOD islet isograft from autoimmune destruction by agarose microencapsulation. Transplant. Proc. 2003, 35:484-485.
162. Hardikar A.A., Risbud M.V., Bhonde R.R. Improved post-cryopreservation recovery following encapsulation of islets in chitosan-alginate microcapsules. Transplant. Proc. 2000, 32:824-825.
163. Calafiore R. Alginate microcapsules for pancreatic islet cell immunoprotection: struggle and progress towards the final cure for type 1 diabetes mellitus. Expert. Opin. Biol. Ther. 2004, 3:201-205.
164. Elliot R.B., Escobar L., Calafiore R., Basta G., Garkavenko O., Vasconcellos A., Bambra C. Transplantation of micro- and macroencapsulated piglet islets into mice and monkeys. Transplant. Proc. 2005, 37:466-469.
165. Elliot R.B., Escobar L., Tan P.L.J., Garkavenko O., Calafiore R., Basta P., Vasconcellos A.V., Emerich D.F., Thanos C., Bambra C. Intraperitoneal alginate-encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates. Transplant. Proc. 2005, 37:3505-3508.
166. Calafiore R., Basta G., Luca G., Lemmi A., Montanucci M.P., Calabrese G., Racanicchi L., Mancuso F., Brunetti P. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care 2006, 29:137-138.
167. Calafiore R., Basta G., Luca G., Lemmi A., Racanicchi L., Mancuso F., Montanucci M.P., Brunetti P. Standard technical procedures for microencapsulation of human islets for graft into nonimmunosuppressed patients with type 1 diabetes mellitus. Transplant. Proc. 2006, 38:1156-1157.
168. Elliott R.B., Escobar L., Tan P.L., Muzina M., Zwine S., Buchanan C. Live encapsulated porcine islets from a type 1 diabetic patient 9.5yr after xenotransplantation. Xenotransplantation 2007, 14:157-161.
169. Grose S. Critics slam Russian trial to test pig pancreas for diabetics. Nat. Med. 2007, 13:390-391.
170. http://www.clinicaltrials.gov.
171. Wyman J.L., Kizilel S., Skarbek R., Zhao X., Connors M., Dillmore W.S., Murphy W.L., Mrksich M., Nagel S.R., Garfinkel M.R. Immunoisolating pancreatic islets by encapsulation with selective withdrawal. Small 2007, 3:683-690.
172. Lee D.Y., Yang K., Lee S., Chae S.Y., Kim K.W., Lee M.K., Han D.J., Byun Y. Optimization of monomethoxy-polyethylene glycol grafting on the pancreatic islet capsules. J. Biomed. Mater. Res. 2002, 62:372-377.
173. Sawhney A.S., Pathak C.P., Hubbell J.A. Modification of islets of Langerhans surfaces with immunoprotective poly(ethylene glycol) coatings via interfacial photopolymerization. Biotechnol. Bioeng. 1994, 44:383-386.
174. Panza J.L., Wagner W.R., Role H.L.R., Rao R.H., Beckman E.J., Russell A.J. Treatment of rat pancreatic islets with reactive PEG. Biomaterials 2000, 21:1155-1164.
175. Jang J.Y., Lee D.Y., Park S.J., Byun Y. Immune reactions of lymphocytes and macrophages against PEG-grafted pancreatic islets. Biomaterials 2004, 25:3663-3669.
176. Lee D.Y., Nam J.H., Byun Y. Functional and histological evaluation of transplantesd pancreatic islets immunoprotected by PEGylation and cyclosporine for 1year. Biomaterials 2007, 28:1957-1966.
177. de Vos P., Hamel A.F., Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia 2002, 45:154-173.
178. Sigrist S., Mechine-Neuville A., Mandes K., Calenda V., Legeay G., Bellocq J.P., Pinget M., Kessler L. Induction of angiogenesis in omentum with vascular endothelial growth factor: influence on the viability of encapsulated rat pancreatic islets during transplantation. J. Vasc. Res. 2003, 40:359-367.
179. Moya M.L., Garfinkel M.R., Liu X., Lucas S., Opara E.C., Greisler H.P., Brey E.M. Fibroblast growth factor-1 (FGF-1) loaded microbeads enhance local capillary neovascularization. J. Surg. Res. 2010, 160:208-212.
180. Teramura Y., Iwata H. Islet encapsulation with living cells for improvement of biocompatibility. Biomaterials 2009, 30:2270-2275.
181. Lin C.C., Anseth K.S. Glucagon-like peptide-1 functionalized PEG hydrogels promote survival and function of encapsulated pancreatic ?-cells. Biomacromolecules 2009, 10:2460-2467.
182. Bünger C.M., Tiefenbach B., Jahnke A., Gerlach C., Freier Th., Schmitz K.P., Hopt U.T., Schareck W., Klar E., de Vos P. Deletion of the tissue response against alginate-PLL capsules by temporary release of coencapsulated steroids. Biomaterials 2005, 26:2353-2360.
183. Omer A., Keegan M., Czismadia E., de Vos P., van Rooijen N., Bonner-Weir S., Weir G.C. Macrophage depletion improves survival of porcine neonatal pancreatic cell clusters contained in alginate macrocapsules transplanted into rats. Xenotransplantation 2003, 10:240-251.
184. Hsu B.R., Chang F.H., Juang J.H., Huang Y.Y., Fu S.H. The rescue effect of 15-deoxyspergualin on intraperitoneal microencapsulated xenoislets. Cell Transplant. 1999, 8:307-315.
185. Stevens B., Yang Y., Mohandas A., Stucker B., Nguyen K.T. A review of materials, fabrication methods, and strategies used to enhance bone regeneration in engineered bone tissues. J. Biomed. Mater. Res. B Appl. Biomater. 2008, 85:573-582.
186. Bieback K., Kern S., Kluter H., Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004, 22:625-634.
187. Zuk P.A. Multilineage cells from human adipose tissue: implications for cell based therapies. Tissue Eng. 2001, 7:211-228.
188. Kimelman N., Pelled G., Helm G.A., Huard J., Schwarz E.M., Gazit D. Review: gene and stem cell-based therapeutics for bone regeneration and repair. Tissue Eng. 2007, 13:1135-1150.
189. Wang X., Wang W., Ma J., Guo X., Yu X., Ma X. Proliferation and differentiation of mouse embryonic stem cells in APA microcapsule: a model for studying the interaction between stem cells and their niche. Biotechnol. Prog. 2006, 22:791-800.
190. M. Endres, N. Wenda, H. Woehlecke, K. Neumann, J. Ringe, C. Erggelet, D. Lerche, C. Kaps, Microencapsulation and chondrogenic differentiation of human mesenchymal progenitor cells from subchondral bone marrow in Ca-alginate for cell injection, Acta Biomater. 6 (2010) 436-444.
191. Abbah S.A., Lu W.W., Chan D., Cheung K.M., Liu W.G., Zhao F., Li Z.Y., Leong J.C., Luk K.D. In vitro evaluation of alginate encapsulated adipose-tissue stromal cells for use as injectable bone graft substitute. Biochem. Biophys. Res. 2006, 347:185-191.
192. Abbah S.A., Lu W.W., Chan D., Cheung K.M.C., Liu W.G., Zhao F., Li Z.Y., Leong J.C.Y., Luk K.D.K. Osteogenic behaviour of alginate encapsulated bone marrow stromal cells: an in vitro study. J. Mater. Sci. Mater. Med. 2008, 19:2113-2119.
193. Suh D.Y., Boden S.D., Louis-Ugbo J., Mayr M., Murakami H., Kim H.S., Minamide A., Hutton W.C. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the nonhuman primate. Spine 2002, 27:353-360.
194. Yamamoto M., Takahashi Y., Tabata Y. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 2003, 24:4375-4383.
195. Gazit D., Turgeman G., Kelly P., Zilberman Y., Moutsatsos I. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy. J. Gene Med. 1999, 1:121-133.
196. Paek H.J., Campaner A.B., Kim J.L., Golden L., Aaron R.K., Ciombor D.M., Morgan J.R., Lysaght M.J. Microencapsulated cells genetically modified to overexpress human transforming growth factor-?1: viability and functionality in allogeneic and xenogeneic implant models. Tissue Eng. 2006, 12:1733-1739.
197. Guillotin B., Bourget C., Remy-Zolgadri M., Bareille R., Fernandez P., Conrad V., Amedee-Vilamitjana J. Human primary endothelial cells stimulate human osteoprogenitor cell differentiation. Cell Physiol. Biochem. 2004, 14:325-332.
198. Clarkin C.E., Emery R.J., Pitsillides A.A., Wheeler-Jones C.P. Evaluation of VEGF mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells. J. Cell Physiol. 2007, 214:537-544.
199. Grellier M., Granja P.L., Fricain J., Bidarra S.J., Renard M., Bareille R., Bourget C., Amédée J., Barbosa M.A. The effect of the co-immobilization of human osteoprogenitors and endotelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials 2009, 30:3271-3278.
200. Malda J., Frondoza C.G. Microcarriers in the engineering of cartilage and bone. Trends Biotechnol. 2006, 24:299-304.
201. Tan H., Huang D., Lao L., Gao G. RGD modified PLGA/gelatin microspheres as microcarriers for chondrocyte delivery. J. Biomed. Mater. Res. B Appl. Biomater. 2009, 91:228-238.
202. Gurevich O., Vexler A., Akiva M., Marx G., Prigozhina T., Levdansky L., Slavin S., Shimon, Shimeliovich I., Gorodetsky R. Fibrin microbeads for isolating and growing bone marrow-derived progenitor cells capable of forming bone tissue. Tissue Eng. 2002, 8:661-672.
203. Barrias C.C., Ribeiro C.C., Lamghari M., Miranda C.S., Barbosa M.A. Proliferation, activity, and osteogenic differentiation of bone marrow stromal cells cultured on calcium titanium phosphate microspheres. J. Biomed. Mater. Res. A 2005, 72:57-66.
204. Fischer E.M., Layrolle P., van Blitterswijk C.A., De Bruijn J.D. Bone formation by mesenchymal progenitor cells cultured on dense and microporous hydroxyapatite particles. Tissue Eng. 2003, 9:1179-1188.
205. Wang C., Gong Y., Lin Y., Shen J., Wang D. A novel gellan gel-based microcarrier for anchorage-dependent cell delivery. Acta Biomater. 2008, 4:1226-1234.
206. Wang C., Gong Y., Zhong Y., Yao Y., Su K., Wang D. The control of anchorage-dependent cell behaviour within a hydrogel/microcarrier system in a osteogenic model. Biomaterials 2009, 30:2259-2269.
207. Wang X., Wenk E., Zhang X., Meinel L., Vunjak-Novakovic G., Kaplan D.L. Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering. J. Control. Release 2009, 134:81-90.
208. Laguna G.R., Tyers P., Barker R.A. The search for a curative cell therapy in Parkinson's disease. J. Neurol. Sci. 2008, 265:32-42.
209. Winkler C., Kirik D., Björklund A. Cell transplantation in Parkinson's disease: how can we make it work?. Trends Neurosci. 2005, 28:86-92.
210. Emerich D.F., Skinner S.J.M., Borlongan C.V., Vasconcellos A., Thanos C.G. The choroid plexus in the rise, fall, and repair of the brain. BioEssays 2005, 27:262-274.
211. Borlogan C.V., Skinner S.J.M., Geaney M., Vasconcellos A.V., Elliot R.B., Emerich D.F. Neuroprotection by encapsulated choroid plexus in a rodent model of Huntington's disease. NeuroReport 2004, 15:2521-2525.
212. Emerich D.F., Thanos C.G., Goddard M., Skinner S.J.M., Geany M.S., Bell W.J., Bintz B., Schneider P., Chu Y., Babu R.S., Borlongan C.V., Boekelheide K., Hall S., Bryant B., Kordower J.H. Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys. Neurobiol. Dis. 2006, 23:471-480.
213. Borlogan C.V., Skinner S.J.M., Geaney M., Vasconcellos A.V., Elliot R.B., Emerich D.F. Intracerebral transplantation of porcine choroid plexus provides structural and functional neuroprotection in a rodent model of stroke. Stroke 2004, 35:2206-2210.
214. Subramanian T., Marchionini D., Potter E.M., Cornfeldt M.L. Striatal xenotransplantation of human retinal pigment epithelial cells attached to microcarriers in hemiparkinsonian rats ameliorates behavioral deficits without provoking a host immune response. Cell Transplant. 2002, 11:207-214.
215. Watts R.L., Raiser C.D., Stover N.P., Cornfeldt M.L., Schweikert A.W., Allen R.C., Subramanian T., Doudet D., Honey C.R., Bakay R.A.E. Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson's disease. J. Neural. Transm. Suppl. 2003, 65:215-227.
216. Titan Pharmaceuticals announces Spheramine(R) Initial Phase IIb Results 2008, http://www.medicalnewstoday.com/articles/113908.php.
217. Liu Y., Kim D., Himes B.T., Chow S.Y., Schallert T., Murray M., Tessler A., Fischer I. Transplants of fibroblasts genetically modified to Express BDNF promote regeneration of adult rat rubrospinal axons and recovery of forelimb function. J. Neurosci. 1999, 19:4370-4387.
218. Tobias C.A., Han S.S.W., Shumsky J.S., Kim D., Tumolo M., Dhoot N.O., Wheatley M.A., Fisher I., Tessler A., Murray M. Alginate encapsulated BDNF-producing fibroblast grafts permit recovery of function alter spinal cord injury in the absence of immune suppression. J. Neurotrauma 2005, 22:138-156.
219. Sakai S., Kawakami K. Development of subsieve-size capsules and application of cell therapy. Therapeutic applications of cell microencapsulation 2009, 23-30. Landes Bioscience, Austin. G. Orive, J.L. Pedraz (Eds.).
220. Sabel M.S., Arora A., Su G., Mathiowitz E., Reineke J.J., Chang A.E. Synergistic effect of intratumoral IL-12 and TNF-? microspheres: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cells. Surgery 2007, 142:749-760.
221. Read T., Sorensen D.R., Mahesparan R., Enger P.Ø., Timpl R., Olsen B.R., Hjelstuen M.H.B., Haraldseth O., Bjerkvig R. Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nat. Biotechnol. 2001, 19:29-34.
222. Teng H., Zhang Y., Wang W., Ma X., Fei J. Inhibition of tumor growth in mice by endostatin derived from abdominal transplanted encapsulated cells. Acta Biochim. Biophys. Sin. 2007, 39:278-284.
223. Cirone P., Bourgeois J.M., Chang P.L. Antiangiogenic cancer therapy with microencapsulated cells. Hum. Gene Ther. 2003, 14:1065-1077.
224. Cirone P., Bourgeois J.M., Shen F., Chang P.L. Combined immunotherapy and antiangiogenic therapy of cancer with microencapsulated cells. Hum. Gene Ther. 2004, 15:945-959.
225. Cirone P., Shen F., Chang P.L. A multiprong approach to cancer gene therapy by coencapsulated cells. Cancer Gene Ther. 2005, 12:369-380.
226. Salmons B., Gunzburg W.H. Therapeutic application of cell microencapsulation in cancer. Therapeutic applications of cell microencapsulation 2009, 92-103. Landes Bioscience, Austin. G. Orive, J.L. Pedraz (Eds.).
227. Löhr M., Müller P., Karle P., Stange J., Mitzner S., Jesnowski R., Nizze H., Nebe B., Liebe S., Salmons B., Gunzburg W.H. Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450. Gene Ther. 1998, 5:1070-1078.
228. Karle P., Müller P., Renz R., Jesnowski R., Saller R., von Rombs K., Nizze H., Liebe S., Gunzburg W.H., Salmons B., Lohr M. Intratumour injection of encapsulated cells producing an oxazaphosphorine activating cytochrome P450 for targeted chemotherapy. Adv. Exp. Med. Biol. 1998, 451:97-106.
229. Löhr M., Hoffmeyer A., Kröger J., Freund M., Hain J., Holle A., Karle P., Knofel W.T., Liebe S., Muller P., Nizze H., Renner M., Saller R.M., Wagner T., Hauenstein K., Gunzburg W.H., Salmons B. Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. Lancet 2001, 357:1591-1592.
230. Löhr J.M., Kröger J.C., Hoffmeyer A., Freund M., Hain J., Holle A., Knöfel W.T., Liebe S., Nizze H., Renner M., Saller R., Müller P., Wagner T., Hauenstein K., Salmons B., Günzbur W.H. Safety, feasibility and clinical benefit of localized chemotherapy using microencapsulated cells for inoperable pancreatic carcinoma in a phase I/II trial. Cancer Ther. 2003, 1:121-131.
231. Günzburg W.H., Salmons B. Cell and gene therapy to improve cancer treatment. Acta Biochim. Pol. 2005, 52:601-607.
232. Orive G., Hernandez R.M., Gascon A.R., Igartua M., Rojas A., Pedraz J.L. Microencapsulation of an anti-VE-cadherin antibody secreting 1B5 hybridoma cells. Biotechnol. Bioeng. 2001, 76:285-294.
233. Templin C., Kotlarz D., Faulhaber J., Schnabel S., Grote K., Salguero G., Luchtefeld M., Hiller K.H., Jakob P., Naim H.Y., Schieffer B., Hilfiker-Kleiner D., Landmesser U., Limbourg F.P., Drexler H. Ex vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction: role of beta-catenin transduction and cell dose. J. Mol. Cell. Cardiol. 2008, 45:394-403.
234. Collins S.D., Baffour R., Waksman R. Cell therapy in myocardial infarction. Cardiovasc. Revasc. Med. 2007, 8:43-51.
235. Jolicoeur E.M., Granger C.B., Fakunding J.L., Mockrin S.C., Grant S.M., Ellis S.G., Weisel R.D., Goodell M.A. Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meeting. Am. Heart J. 2007, 153:732-742.
236. Mazhari R., Hare J.M. Advances in cell-based therapy for structural heart disease. Prog. Cardiovasc. Dis. 2007, 49:387-395.
237. Tousoulis D., Briasoulis A., Antoniades C., Stefanadi E., Stefanadis C. Heart regeneration: what cells to use and how?. Curr. Opin. Pharmacol. 2008, 8:211-216.
238. D. Choi, K. Hwang, K. Lee, Y. Kim, Ischemic heart diseases: current treatments and future, J. Control. Release 140 (2009) 194-202.
239. Madeddu P. Therapeutic angiogenesis and vasculogenesis for tissue regeneration. Exp. Physiol. 2005, 90:315-326.
240. Jacobs J. Combating cardiovascular disease with angiogenic therapy. Drug Discov. Today 2007, 12:1040-1045.
241. Losordo D.W., Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 2004, 109:2692-2697.
242. Zang H., Zhu S.J., Wang W., Wey Y.J., Hu S.S. Transplantation of microencapsulated genetically modified xenogenic cells augments angiogenesis and improves heart function. Gene Ther. 2008, 15:40-48.
243. Jeon Y., Kwak K., Kim S., Kim Y., Lim J., Baek W. Intrathecal implants of microencapsulated xenogenic chromaffin cells provide a long-term source of analgesic substances. Transplant. Proc. 2006, 38:3061-3065.
244. Livett B.G., Dean D.M., Whelan L.G., Udenfriend S., Rossier J. Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells. Nature 1981, 289:317-319.
245. Dixit V., Darvasi R., Arthur M., Brezina M., Lewin K., Gitnick G. Restoration of liver function in Gunn rats without immunosuppression using transplanted microencapsulated hepatocytes. Hepatology 1990, 12:1342-1349.
246. Wong H., Chang T.M. Bioartificial liver: implanted artificial cells microencapsulated living hepatocytes increases survival of liver failure rats. Int. J. Artif. Organs 1986, 9:335-336.
247. Liu Z.C., Chang T.M. Coencapsulation of hepatocytes and bone marrow stem cells: in vitro conversion of ammonia and in vivo lowering of bilirubin in hyperbilirubemia Gunn rats. Int. J. Artif. Organs 2003, 26:491-497.
248. Liu Z.C., Chang T.M.S. Coencapsulation of hepatocytes and bone marrow cells: in vitro and in vivo studies. Biotechnol. Annu. Rev. 2006, 12:137-151.
249. Liu Z.C., Chang T.M.S. Transdifferentiation of bioencapsulated bone marrow cells into hepatocyte-like cells in the 90% hepatectomized rat model. Liver Transpl. 2006, 12:566-572.
250. Ponce S., Orive G., Hernández R.M., Gascón A.R., Canals J.M., Muñoz M.T., Pedraz J.L. In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules. J. Control. Release 2006, 116:28-34.